Premium
Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from randomized controlled trials
Author(s) -
Hermann Robert,
Cnota Peter,
Maus Joachim
Publication year - 2012
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2012.04176.x
Subject(s) - drug , medicine , randomized controlled trial , quality (philosophy) , pharmacology , intensive care medicine , risk analysis (engineering) , surgery , philosophy , epistemology